X·CON 2019 – Healthtech →
September 14th, 2016
Cambridge, MA-based C4 Therapeutics has named chief scientific officer Andrew Phillips its president. Phillips is taking over for former president and CEO Jason Fisherman, who has resigned to pursue other opportunities.
Ben Fidler is Xconomy's Deputy Editor, Biotechnology. You can e-mail him at email@example.com Follow @benthefidler
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Remain compliant and ensure optimal productivity
Tax credits help tech innovators attract capital, fuel growth
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.